Agriculture, Rural Development, and Related Agencies Appropriations for 1982: Hearings Before a Subcommitee of the Committee on Appropriations, House of Representatives, Ninety-sixth Congress, First Session, Parts 5-6U.S. Government Printing Office, 1981 - United States |
From inside the book
Results 1-5 of 100
Page 16
... regulatory drug authorities . Last October , after con- siderable planning , FDA sponsored the first international confer- ence of drug regulatory authorities to try to do just exactly what you are suggesting and what we agree with ...
... regulatory drug authorities . Last October , after con- siderable planning , FDA sponsored the first international confer- ence of drug regulatory authorities to try to do just exactly what you are suggesting and what we agree with ...
Page 20
... regulation , and we do not want to put regula- tion needlessly in the way of getting an orphan drug or any other drug to market . Mr. WHITTEN . Regulations stand in the way and you are against the regulations , but who wrote the regulations ...
... regulation , and we do not want to put regula- tion needlessly in the way of getting an orphan drug or any other drug to market . Mr. WHITTEN . Regulations stand in the way and you are against the regulations , but who wrote the regulations ...
Page 21
... regulation , and we do not want to put regula- tion needlessly in the way of getting an orphan drug or any other drug to market . Mr. WHITTEN . Regulations stand in the way and you are against the regulations , but who wrote the regulations ...
... regulation , and we do not want to put regula- tion needlessly in the way of getting an orphan drug or any other drug to market . Mr. WHITTEN . Regulations stand in the way and you are against the regulations , but who wrote the regulations ...
Page 36
... regulatory provisions that have no relation to pending applications since the GAO report was published . Dr. NOVITCH . FDA is heavily committed to an extensive revision of the IND and NDA regulations to modernize the regulatory re ...
... regulatory provisions that have no relation to pending applications since the GAO report was published . Dr. NOVITCH . FDA is heavily committed to an extensive revision of the IND and NDA regulations to modernize the regulatory re ...
Page 45
... REGULATORY AGENCIES Q : Here is a list of some government regulatory agencies concerned with public health , safety , and environmental hazards . How would you rate each of the following on the job they are doing to make our society ...
... REGULATORY AGENCIES Q : Here is a list of some government regulatory agencies concerned with public health , safety , and environmental hazards . How would you rate each of the following on the job they are doing to make our society ...
Other editions - View all
Common terms and phrases
action activities additional aflatoxin agency agency's amended ampicillin analysis analyzed animal drugs appropriate approval approximately benzodiazepines blood budget Bureau carcinogen chemical cimetidine clinical Committee commodities compliance Conduct consumer contamination cosmetic costs determine digoxin dispensers distribution dose Drug Administration Drug Applications effects established Estimated evaluation facilities FDA's Federal Register feed Food and Drug Food Safety FSQS funds HOUSTON human implementation increase industry initial inspection investigations laboratory manufacturers meat and poultry medical devices ment methods methoxsalen million monitoring NOVITCH orphan drugs patient package inserts percent personnel pesticide petition pharmacists pharmacy phenytoin potential POULTRY PRODUCTS PPIs prescription drug problems procedures proposed radiation regulations regulatory reports request requirements response revised risk samples scientific September 12 Service SODIUM specific standards submitted testing thiazide tion toxic Toxicology USDA vaccines warfarin WHITTEN